PI3K/Akt/mTOR and MAPK/ERK Pathway Activation In research settings, IGF-1 LR3 activates the PI3K/Akt pathway (involved in survival, glucose metabolism, and protein synthesis), the RAS/MAPK pathway (regulating growth and differentiation), the mTOR pathway (governing anabolic protein synthesis signalling), and IRS-1/2 cross-talk with insulin receptor signalling the full complement of IGF-1R-mediated downstream effects
Semaglutide tends to produce a more gradual onset of side effects, allowing many patients to adapt as their bodies adjust to the medication
Ferdinand KC, White WB, Calhoun DA, Lonn EM, Sager PT, Brunelle R, et al
Modulation of immunity and inflammation by the mineralocorticoid receptor and aldosterone